🇺🇸 FDA
Patent

US 12357604

Topical formulations of cannabinoids and use thereof in the treatment of pain

granted A61KA61K31/01A61K31/045

Quick answer

US patent 12357604 (Topical formulations of cannabinoids and use thereof in the treatment of pain) held by INMED PHARMACEUTICALS INC. expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
INMED PHARMACEUTICALS INC.
Grant date
Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/01, A61K31/045, A61K31/05, A61K31/08